Literature DB >> 32259798

Smartphone-based remote assessment of upper extremity function for multiple sclerosis using the Draw a Shape Test.

A P Creagh1, C Simillion, A Scotland, F Lipsmeier, C Bernasconi, S Belachew, J van Beek, M Baker, C Gossens, M Lindemann, M De Vos.   

Abstract

OBJECTIVE: Smartphone devices may enable out-of-clinic assessments in chronic neurological diseases. We describe the Draw a Shape (DaS) Test, a smartphone-based and remotely administered test of Upper Extremity (UE) function developed for people with multiple sclerosis (PwMS). This work introduces DaS-related features that characterise UE function and impairment, and aims to demonstrate how multivariate modelling of these metrics can reliably predict the 9-Hole Peg Test (9HPT), a clinician-administered UE assessment in PwMS. APPROACH: The DaS Test instructed PwMS and healthy controls (HC) to trace predefined shapes on a smartphone screen. A total of 93 subjects (HC, n = 22; PwMS, n = 71) contributed both dominant and non-dominant handed DaS tests. PwMS subjects were characterised as those with normal (nPwMS, n = 50) and abnormal UE function (aPwMS, n = 21) with respect to their average 9HPT time (≤ or > 22.7 (s), respectively). L 1-regularization techniques, combined with linear least squares (OLS, IRLS), or non-linear support vector (SVR) or random forest (RFR) regression were investigated as functions to map relevant DaS features to 9HPT times. MAIN
RESULTS: It was observed that average non-dominant handed 9HPT times were more accurately predicted by DaS features (r 2 = 0.41, [Formula: see text] 0.05; MAE: 2.08 ± 0.34 (s)) than average dominant handed 9HPTs (r 2 = 0.39, [Formula: see text] 0.05; MAE: 2.32 ± 0.43 (s)), using simple linear IRLS ([Formula: see text] 0.01). Moreover, it was found that the Mean absolute error (MAE) in predicted 9HPTs was comparable to the variability of actual 9HPT times within HC, nPwMS and aPwMS groups respectively. The 9HPT however exhibited large heteroscedasticity resulting in less stable predictions of longer 9HPT times. SIGNIFICANCE: This study demonstrates the potential of the smartphone-based DaS Test to reliably predict 9HPT times and remotely monitor UE function in PwMS.

Entities:  

Mesh:

Year:  2020        PMID: 32259798     DOI: 10.1088/1361-6579/ab8771

Source DB:  PubMed          Journal:  Physiol Meas        ISSN: 0967-3334            Impact factor:   2.833


  9 in total

1.  The Path Forward for Digital Measures: Suppressing the Desire to Compare Apples and Pineapples.

Authors:  Carrie R Houts; Bray Patrick-Lake; Ieuan Clay; R J Wirth
Journal:  Digit Biomark       Date:  2020-11-26

2.  Digital biomarkers can highlight subtle clinical differences in radiologically isolated syndrome compared to healthy controls.

Authors:  Mikael Cohen; Lydiane Mondot; Salim Fakir; Cassandre Landes; Christine Lebrun
Journal:  J Neurol       Date:  2020-10-19       Impact factor: 4.849

Review 3.  Evaluation, Acceptance, and Qualification of Digital Measures: From Proof of Concept to Endpoint.

Authors:  Jennifer C Goldsack; Ariel V Dowling; David Samuelson; Bray Patrick-Lake; Ieuan Clay
Journal:  Digit Biomark       Date:  2021-03-23

4.  Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test.

Authors:  Komi S Messan; Linh Pham; Thomas Harris; Yujin Kim; Vanessa Morgan; Peter Kosa; Bibiana Bielekova
Journal:  Front Med Technol       Date:  2022-02-01

Review 5.  Remote Assessments of Hand Function in Neurological Disorders: Systematic Review.

Authors:  Arpita Gopal; Wan-Yu Hsu; Diane D Allen; Riley Bove
Journal:  JMIR Rehabil Assist Technol       Date:  2022-03-09

6.  Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.

Authors:  Florian Lipsmeier; Kirsten I Taylor; Ronald B Postuma; Ekaterina Volkova-Volkmar; Timothy Kilchenmann; Brit Mollenhauer; Atieh Bamdadian; Werner L Popp; Wei-Yi Cheng; Yan-Ping Zhang; Detlef Wolf; Jens Schjodt-Eriksen; Anne Boulay; Hanno Svoboda; Wagner Zago; Gennaro Pagano; Michael Lindemann
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

7.  Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial.

Authors:  Kaylene M Young; Bruce V Taylor; Kalina Makowiecki; Natasha Stevens; Carlie L Cullen; Amin Zarghami; Phuong Tram Nguyen; Lewis Johnson; Jennifer Rodger; Mark R Hinder; Michael Barnett
Journal:  Trials       Date:  2022-08-03       Impact factor: 2.728

8.  Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.

Authors:  Larsson Omberg; Abhishek Pratap; Daniel Grant; Ashok Vegesna; Meghasyam Tummalacherla; Stanley Cohan; Chinmay Deshpande; Lara Mangravite
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-27       Impact factor: 4.773

9.  A smartphone sensor-based digital outcome assessment of multiple sclerosis.

Authors:  Xavier Montalban; Jennifer Graves; Luciana Midaglia; Patricia Mulero; Laura Julian; Michael Baker; Jan Schadrack; Christian Gossens; Marco Ganzetti; Alf Scotland; Florian Lipsmeier; Johan van Beek; Corrado Bernasconi; Shibeshih Belachew; Michael Lindemann; Stephen L Hauser
Journal:  Mult Scler       Date:  2021-07-14       Impact factor: 6.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.